Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Pfizer Inc. buy FXX

Start price
€35.01
12.12.20 / 50%
Target price
-
2021-12-12
Performance (%)
-19.18%
Price
€27.97
01.03.21
This prediction is currently active. The price of Pfizer Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -19.18%. A total of €0.32 was paid as dividends for this prediction. This prediction currently runs until 2021-12-12. The prediction end date can be changed by FXX at any time. FXX has 50% into this prediction

According to FXX what are the pros and cons of Pfizer Inc. for the foreseeable future?

Pros
Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
High dividend yield expected
ROE higher than 10% per year
Good culture
Growths faster than the competition
Top 10 in its market
Known brand
Future proof or reliable business model
Good rating
Standard Investments for future growth
Capable Management
Leading role in innovation
Some uniques
Cons
Significant cyclical dependencies
negative Cash Flow expected
Risky balance sheet
Dependend from some customers or products
Sustainability is little important
Higher risks for its business
Increased challenges to pay loans and raise capital

Comments by FXX for this prediction

In the thread Pfizer Inc. diskutieren

Buy Pfizer Inc.